Disulphide-isomerase-enabled shedding of tumour-associated NKG2D ligands

Nature

Volumn 447, Issue 7143, 2007, Pages 482-486

  Kaiser, Brett K ^a   Yim, Daesong ^a   Chow, I Ting ^a   Gonzalez, Segundo ^a,b   Dai, Zhenpeng ^a   Mann, Henning H ^a   Strong, Roland K ^a   Groh, Veronika ^a   Spies, Thomas ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF OVIEDO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

5,5' DITHIOBIS(2 NITROBENZOIC ACID); ARSENOSOBENZENE; DISULFIDE ISOMERASE; ENDOPLASMIC RETICULUM PROTEIN 5; MICA PROTEIN; NATURAL KILLER CELL RECEPTOR NKG2D; P5 PROTEIN; PROTEIN; RECOMBINANT PROTEIN; THIOREDUCTASE; TRICHLOROACETIC ACID; UNCLASSIFIED DRUG;

ENZYME ACTIVITY; GENETIC ENGINEERING; GENOTOXICITY; LIGAND; MAJOR HISTOCOMPATIBILITY COMPLEX; PROTEIN; TUMOR;

ARTICLE; CD4+ T LYMPHOCYTE; CELL CULTURE; CELL MEMBRANE; CELL STRAIN HCT116; CELL STRAIN U937; CELL SURFACE; CHEMICAL BOND; COLON CARCINOMA; COMPLEX FORMATION; CONFORMATIONAL TRANSITION; ENDOPLASMIC RETICULUM; ENZYME ACTIVITY; GENE DELETION; GENE SILENCING; HELA CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOPRECIPITATION; MELANOMA CELL; MYELOMA CELL; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; PROTEIN DEGRADATION;

EID: 34249295619     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature05768     Document Type: Article

References (28)

1. Cerwenka, A., Baron, J. L. & Lanier, L. L. Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo. Proc. Natl Acad. Sci. USA 98, 11521-11526 (2001).
2. Diefenbach, A., Jensen, E. R., Jamieson, A. M. & Raulet, D. H. Rae1 and H60 ligands of the NKG2D receptor stimulate tumor immunity. Nature 413, 165-171 (2001).
3. Girardi, M. et al. Regulation of cutaneous malignancy by γδ T cells. Science 294, 605-609 (2001).
4. Gasser, S., Orsulic, S., Brown, E. J. & Raulet, D. H. The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor. Nature 436, 1186-1190 (2005).
5. Smyth, M. J. et al. NKG2D function protects the host from tumor initiation. J. Exp. Med. 202, 583-588 (2005).
6. Gonzalez, S., Groh, V. & Spies, T. Immunobiology of human NKG2D and its ligands. Curr. Top. Microbiol. Immunol. 298, 121-138 (2006).
7. Groh, V., Wu, J., Yee, C. & Spies, T. Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation. Nature 419, 734-738 (2002).
8. Doubrovina, E. S. et al. Evasion from NK cell immunity by MHC class I chainrelated molecules expressing colon carcinoma. J. Immunol. 171, 6891-6899 (2003).
9. Groh, V., Smythe, K., Dai, Z. & Spies, T. Fas ligand-mediated paracrine T cell regulation by the receptor NKG2D in tumor immunity. Nature Immunol. 7, 755-762 (2006).
10. Ellgaard, L. & Ruddock, L. W. The human protein disulphide isomerase family: substrate interactions and functional properties. EMBO Rep. 6, 28-32 (2005).
11. Jinushi, M., Hodi, F. S. & Dranoff, G. Therapy-induced antibodies to MHC class I chain-related protein A antagonize immune suppression and stimulate antitumor cytotoxicity. Proc. Natl Acad. Sci. USA 103, 9190-9195 (2006).
12. Oppenheim, D. E. et al. Sustained localized expression of ligand for the activating NKG2D receptor impairs natural cytotoxicity in vivo and reduces tumor immunosurveillance. Nature Immunol. 6, 928-937 (2005).
13. Bauer, S. et al. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 285, 727-729 (1999).
14. Cosman, D. et al. ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. Immunity 14, 123-133 (2001).
15. Kikuchi, M., Doi, E., Tsujimoto, I., Horibe, T. & Tsujimoto, Y. Functional analysis of human P5, a protein disulfide isomerase homologue. J. Biochem. 132, 451-455 (2002).
16. Turano, C., Coppari, S., Altieri, F. & Ferraro, A. P. Proteins of the PDI family: unpredicted non-ER localizations and functions. J. Cell. Physiol. 193, 154-163 (2002).
17. Jordan, P. A. & Gibbins, J. M. Extracellular disulfide exchange and the regulation of cellular function. Antioxid. Redox Signal. 8, 312-324 (2006).
18. Gallina, A. et al. Inhibitors of protein-disulfide isomerase prevent cleavage of disulfide bonds in receptor-bound glycoprotein 120 and prevent HIV-1 entry. J. Biol. Chem. 277, 50579-50588 (2002).
19. Frand, A. R. & Kaiser, C. A. Ero1p oxidizes protein disulfide isomerase in a pathway for disulfide bond formation in the endoplasmic reticulum. Mol. Cell 4, 469-477 (1999).
20. Essex, D. W., Chen, K. & Swiatkowska, M. Localization of protein disulfide isomerase to the external surface of the platelet plasma membrane. Blood 86, 2168-2173 (1995).
21. Groh, V. et al. Broad tumor-associated expression and recognition by tumor-derived γδ T cells of MICA and MICB. Proc. Natl Acad. Sci. USA 96, 6879-6884 (1999).
22. Li, P. et al. Crystal structure of the MHC class I homolog MIC-A, a γδ T cell ligand. Immunity 10, 577-584 (1999).
23. Salih, H. R., Rammensee, H.-G. & Steinle, A. Down-regulation of MICA on human tumors by proteolytic shedding. J. Immunol. 169, 4098-4102 (2002).
24. Groh, V. et al. Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium. Proc. Natl Acad. Sci. USA 93, 12445-12450 (1996).
25. Matthias, L. J. et al. Disulfide exchange in domain 2 of CD4 is required for entry of HIV-1. Nature Immunol. 3, 727-732 (2002).
26. Ahamed, J. et al. Disulfide isomerization switches tissue factor from coagulation to cell signaling. Proc. Natl Acad. Sci. USA 103, 13932-13937 (2006).
27. Maekawa, A., Schmidt, B. & Fazekas de St.. Groth, B. Sanejouand, Y.-H. & Hogg, P. J. Evidence for a domain-swapped CD4 dimer as the coreceptor for binding to class II MHC. J. Immunol. 176, 6873-6878 (2006).
28. Li, P. et al. Complex structure of the actiavting immunoreceptor NKG2D and its MHC class I-like ligand MICA. Nature Immunol. 2, 443-451 (2001).